Cost utility of tumour necrosis factor-α inhibitors for rheumatoid arthritis: an application of Bayesian methods for evidence synthesis in a Markov model CM Nguyen, M Bounthavong, MAS Mendes, MLD Christopher, JN Tran, ... Pharmacoeconomics 30, 575-593, 2012 | 36 | 2012 |
Association of copayment with likelihood and level of adherence in new users of statins: a retrospective cohort study JH Watanabe, R Kazerooni, M Bounthavong Journal of Managed Care Pharmacy 20 (1), 43-50, 2014 | 28 | 2014 |
Comparison of an intensive pharmacist-managed telephone clinic with standard of care for tobacco cessation in a veteran population T Chen, R Kazerooni, EM Vannort, K Nguyen, S Nguyen, J Harris, ... Health Promotion Practice 15 (4), 512-520, 2014 | 25 | 2014 |
Evaluation of celecoxib addition to pain protocol after total hip and knee arthroplasty stratified by opioid tolerance R Kazerooni, MH Tran The Clinical Journal of Pain 31 (10), 903-908, 2015 | 24 | 2015 |
Retrospective evaluation of inpatient celecoxib use after total hip and knee arthroplasty at a Veterans Affairs Medical Center R Kazerooni, M Bounthavong, JN Tran, DT Boggie, RS Meyer The Journal of arthroplasty 27 (6), 1033-1040, 2012 | 23 | 2012 |
Cost-effectiveness analysis of intravenous levetiracetam versus intravenous phenytoin for early onset seizure prophylaxis after neurosurgery and traumatic brain injury R Kazerooni, M Bounthavong ClinicoEconomics and Outcomes Research, 15-23, 2010 | 23 | 2010 |
Cost-utility analysis of botulinum toxin type A products for the treatment of cervical dystonia R Kazerooni, C Broadhead American Journal of Health-System Pharmacy 72 (4), 301-307, 2015 | 22 | 2015 |
Association of copayment and statin adherence stratified by socioeconomic status R Kazerooni, M Bounthavong, JH Watanabe Annals of Pharmacotherapy 47 (11), 1463-1470, 2013 | 21 | 2013 |
Predictors of adherence to hormonal contraceptives in a female veteran population R Kazerooni, A Takizawa, K Vu Contraception 89 (4), 292-298, 2014 | 18 | 2014 |
Topiramate-associated weight loss in a veteran population R Kazerooni, J Lim Military medicine 181 (3), 283-286, 2016 | 16 | 2016 |
Association between statin adherence and cholesterol level reduction from baseline in a veteran population R Kazerooni, JH Watanabe, M Bounthavong Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 33 (10 …, 2013 | 16 | 2013 |
Association of copayment and socioeconomic status with hormonal contraceptive adherence in a female veteran population R Kazerooni, K Vu, A Takizawa, C Broadhead, AP Morreale Women's Health Issues 24 (2), e237-e241, 2014 | 13 | 2014 |
IncobotulinumtoxinA for migraine: a retrospective case series R Kazerooni, J Lim, PDA Blake, S Lessig Clinical Therapeutics 37 (8), 1860-1864, 2015 | 12 | 2015 |
Botulinum toxin type A overdoses: analysis of the FDA adverse event reporting system database R Kazerooni, EP Armstrong Clinical Drug Investigation 38, 867-872, 2018 | 9 | 2018 |
Predictors of pregnancy in female veterans receiving a hormonal contraceptive pill, patch, or ring R Kazerooni, A Blake, J Thai Annals of Pharmacotherapy 49 (12), 1284-1290, 2015 | 6 | 2015 |
A tobacco cessation treatment model using telehealth: A pilot evaluation in Veterans TC Chen, DE Christofferson, K Hamlett-Berry, R Kazerooni, ... Journal of Telemedicine and Telecare 20 (3), 161-163, 2014 | 5 | 2014 |
Comparison of botulinum toxins for treatment of movement disorders: real-world utilization and cost analysis in a national Medicare population R Kazerooni, JH Watanabe Journal of managed care & specialty pharmacy 27 (4), 478-487, 2021 | 3 | 2021 |
Disparities in access to spasticity chemodenervation specialists in the United States: a national analysis of medicare data R Kazerooni, S Healy, M Verduzco-Gutierrez MOVEMENT DISORDERS 36, S157-S157, 2021 | 2 | 2021 |
Decreased Therapeutic Effect over Time Amongst Botulinum Toxin Type A Agents (1837) R Kazerooni Neurology 96 (15 Supplement), 2021 | 2 | 2021 |
Contraceptive Care in the Veterans Health Administration EB Yecies, CP Judge-Golden, L Callegari, S Borrero Seminars in reproductive medicine 37 (01), 024-031, 2019 | 2 | 2019 |